Sign up
Subscribe to our interventional cardiology newsletter
Sign up
Subscribe to our interventional cardiology newsletter
As a subscriber you will benefit from:
Publications
Featuring the latest cardiology news, clinical trials and real-world evidence in aortic stenosis (AS) management.
Panel discussions
Involving leading cardiologists debating the latest topics in transcatheter aortic valve implantation (TAVI) and AS management.
Conference headlines
Providing insights into the major developments from the latest cardiology events.
Guidelines updates
Highlighting the areas of change within any updated aortic stenosis treatment guidelines.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
Edwards, Edwards Lifesciences, the stylized E logo, COMMENCE, Edwards SAPIEN, Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, PARTNER, RESILIA, SAPIEN, SAPIEN 3, and SAPIEN 3 Ultra are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.